MedPath

To compare the effectiveness of oral drugs Acetazolamide and Topiramate in post surgery cases of spontaneous brain fluid leaks

Phase 2
Conditions
Health Condition 1: R299- Unspecified symptoms and signs involving the nervous and musculoskeletal systems
Registration Number
CTRI/2024/07/070355
Lead Sponsor
Dr Devendra Shekhawat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients who are diagnosed as spontaneous CSF rhinorrhea and who

will undergo Endoscopic repair of the leak.

All sexes.

Revision Endoscopic repair of defect.

Exclusion Criteria

Patients with other causes of CSF rhinorrhea.

Patients who develop intraop complications which require specific post op management.

Patients who develop post op meningitis.

Patients who do not give consent for the study.

Patients who fail to turn up for follow up assessment.

Any contraindication to Magnetic resonance (MR) imaging.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Topiramate is a better drug in comparison to Acetazolamide in reducing CSF pressure in post op patients who underwent endoscopic repair of spontaneous CSF leaks.Timepoint: 1 month 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
either drug being better in terms of complaince, cost effectiveness and side effect profile at maximum tolerable dose.Timepoint: 1 month 3 months and 6 months
© Copyright 2025. All Rights Reserved by MedPath